CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis

Amanda Sosulski; Heiko Horn; Lihua Zhang; Caroline Coletti; Vinod Vathipadiekal; Cesar M. Castro; Michael J. Birrer; Osamu Nagano; Hideyuki Saya; Kasper Lage; Patricia K. Donahoe; David Pépin

doi:10.1371/journal.pone.0156595

Loading metrics

Open Access

Peer-reviewed

Research Article

CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis

Amanda Sosulski ,

Contributed equally to this work with: Amanda Sosulski, Heiko Horn

Affiliations Pediatric Surgical Research Laboratories, Massachusetts General Hospital, Department of Surgery, Boston, Massachusetts, United States of America, Department of Surgery, Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Heiko Horn ,

Contributed equally to this work with: Amanda Sosulski, Heiko Horn

Affiliations Pediatric Surgical Research Laboratories, Massachusetts General Hospital, Department of Surgery, Boston, Massachusetts, United States of America, Broad Institute, Cambridge, Massachusetts, United States of America
⨯
Lihua Zhang,

Affiliations Pediatric Surgical Research Laboratories, Massachusetts General Hospital, Department of Surgery, Boston, Massachusetts, United States of America, Department of Surgery, Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Caroline Coletti,

Affiliations Pediatric Surgical Research Laboratories, Massachusetts General Hospital, Department of Surgery, Boston, Massachusetts, United States of America, Department of Surgery, Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Vinod Vathipadiekal,

Affiliations Gynecological Oncology, Massachusetts General Hospital, Department of Medicine, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Cesar M. Castro,

Affiliations Gynecological Oncology, Massachusetts General Hospital, Department of Medicine, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Michael J. Birrer,

Affiliations Gynecological Oncology, Massachusetts General Hospital, Department of Medicine, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Osamu Nagano,

Affiliations Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan, Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Tokyo, Japan
⨯
Hideyuki Saya,

Affiliations Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan, Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Tokyo, Japan
⨯
Kasper Lage,

Affiliations Pediatric Surgical Research Laboratories, Massachusetts General Hospital, Department of Surgery, Boston, Massachusetts, United States of America, Broad Institute, Cambridge, Massachusetts, United States of America
⨯
Patricia K. Donahoe,

Affiliations Pediatric Surgical Research Laboratories, Massachusetts General Hospital, Department of Surgery, Boston, Massachusetts, United States of America, Department of Surgery, Harvard Medical School, Boston, Massachusetts, United States of America, Broad Institute, Cambridge, Massachusetts, United States of America
⨯
David Pépin

* E-mail: dpepin@mgh.harvard.edu

Affiliations Pediatric Surgical Research Laboratories, Massachusetts General Hospital, Department of Surgery, Boston, Massachusetts, United States of America, Department of Surgery, Harvard Medical School, Boston, Massachusetts, United States of America, Broad Institute, Cambridge, Massachusetts, United States of America
⨯

CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis

Amanda Sosulski,
Heiko Horn,
Lihua Zhang,
Caroline Coletti,
Vinod Vathipadiekal,
Cesar M. Castro,
Michael J. Birrer,
Osamu Nagano,
Hideyuki Saya,
Kasper Lage

Published: June 2, 2016
https://doi.org/10.1371/journal.pone.0156595

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Ovarian cancer
Is the Subject Area "Ovarian cancer" applicable to this article?

Thanks for your feedback.
Ascites
Is the Subject Area "Ascites" applicable to this article?

Thanks for your feedback.
Prognosis
Is the Subject Area "Prognosis" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Gastrointestinal cancers
Is the Subject Area "Gastrointestinal cancers" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.